Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Molecular Biology

Background:

• Cyclic peptides containing tryptophan, arginine, and cysteine [(WR)5C] can form gadolinium nanoparticles [(WR)5C]-GdNPs].
• Efficient and non-toxic delivery systems are crucial for nucleic acid-based therapeutics.

Purpose of the Study:

• To evaluate the potential of [(WR)5C]-GdNPs as a delivery vehicle for small interfering RNA (siRNA).
• To assess the cytotoxicity, cellular uptake, and gene silencing efficacy of [(WR)5C]-GdNPs loaded with siRNA.

Main Methods:

• Synthesis of peptide-capped gadolinium nanoparticles [(WR)5C]-GdNPs].
• Cytotoxicity assays using human leukemia (CCRF-CEM) and breast cancer (MDA-MB-231) cell lines.
• Fluorescence-activated cell sorting (FACS) and confocal microscopy for cellular uptake studies.
• Western blot analysis to determine gene silencing efficiency of STAT-3 protein.

Main Results:

• [(WR)5C]-GdNPs exhibited low cytotoxicity (~93% cell viability) in cancer cell lines at 50 µM.
• Cellular uptake of siRNA was enhanced over 10-fold in the presence of [(WR)5C]-GdNPs.
• Significant reduction (~62%) in STAT-3 protein levels was achieved using [(WR)5C]-GdNPs for siRNA delivery.
• Cellular membrane integrity remained intact after incubation with the nanoparticles.

Conclusions:

• [(WR)5C]-GdNPs are effective and non-toxic intracellular siRNA transporters.
• These nanoparticles show promise as a transfection agent for nucleic acid-based therapeutics.